Gyre Therapeutics, Inc.
GYRE
$7.01
-$0.64-8.37%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -12.70% | 10.46% | 81.88% | 12.07% | 6.29% |
| Total Receivables | 37.86% | 5.69% | 12.61% | -22.76% | 40.33% |
| Inventory | 14.87% | -0.08% | 12.48% | 24.32% | -0.66% |
| Prepaid Expenses | -53.43% | 6.37% | -66.90% | 586.38% | 13.13% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -5.09% |
| Total Current Assets | 3.85% | 7.99% | 33.36% | 5.65% | 18.20% |
|
|
|||||
| Total Current Assets | 3.85% | 7.99% | 33.36% | 5.65% | 18.20% |
| Net Property, Plant & Equipment | -0.71% | 0.03% | -0.86% | -2.26% | -2.75% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 26.92% | -2.32% | -2.38% | 198.12% | 2.53% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -27.67% | 7.68% | 2.01% | 38.66% | -45.05% |
| Total Assets | 4.23% | 4.41% | 17.61% | 3.50% | 0.13% |
|
|
|||||
| Total Accounts Payable | -77.70% | 683.10% | -41.80% | 12.96% | -64.36% |
| Total Accrued Expenses | 27.76% | -25.70% | 32.91% | 3.00% | 13.95% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.60% | 0.64% | -22.73% | 12.90% | 2.74% |
| Total Finance Division Other Current Liabilities | 3.21% | 50.83% | -58.82% | -9.69% | 69.05% |
| Total Other Current Liabilities | 3.21% | 50.83% | -58.82% | -9.69% | 69.05% |
| Total Current Liabilities | 14.91% | -5.95% | -10.91% | -2.69% | 32.62% |
|
|
|||||
| Total Current Liabilities | 14.91% | -5.95% | -10.91% | -2.69% | 32.62% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -43.78% | -30.09% | -1.15% | -11.86% | -19.62% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -4.64% | 0.09% | -3.59% | -13.42% | -39.69% |
| Total Liabilities | 8.56% | -5.32% | -8.97% | -5.61% | 0.89% |
|
|
|||||
| Common Stock & APIC | 2.94% | 3.53% | 16.82% | 1.46% | 1.41% |
| Retained Earnings | -2.71% | 5.37% | 0.65% | 3.83% | -0.14% |
| Treasury Stock & Other | 54.18% | 25.67% | 8.00% | 4.27% | -174.52% |
| Total Common Equity | 4.03% | 10.75% | 35.09% | 7.59% | 0.22% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.03% | 10.75% | 35.09% | 7.59% | 0.22% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 2.13% | -5.14% | 3.42% | 3.12% | -0.60% |
| Total Equity | 3.54% | 6.16% | 24.10% | 6.00% | -0.07% |
|
|
|||||